ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association

MeSH terms

• American Heart Association
• Aryl Hydrocarbon Hydroxylases / genetics*
• Cardiovascular Diseases / drug therapy*
• Cardiovascular Diseases / epidemiology
• Cardiovascular Diseases / genetics
• Clopidogrel
• Contraindications
• Cytochrome P-450 CYP2C19
• Drug Labeling*
• Humans
• Platelet Aggregation Inhibitors* / adverse effects
• Platelet Aggregation Inhibitors* / pharmacokinetics
• Practice Guidelines as Topic
• Risk Factors
• Ticlopidine / adverse effects
• Ticlopidine / analogs & derivatives*
• Ticlopidine / pharmacokinetics
• United States